18.54

0.65% +0.1276

Privia Health Group Inc (PRVA)

Overview News Price History Option Chain Financials Discussions Forecast

Privia Health Group Inc stock is currently priced at $18.54, with a 24-hour trading volume of 373.04K. It has seen a +0.65% increased in the last 24 hours and a +1.53% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $18.31 pivot point. If it approaches the $18.69 resistance level, significant changes may occur.

Previous Close:

$18.41

Open:

$18.82

24h Volume:

373.04K

Market Cap:

$2.20B

Revenue:

$1.66B

Net Income/Loss:

$23.08M

P/E Ratio:

59.80

EPS:

0.31

Net Cash Flow:

$80.67M

1W Performance:

+1.48%

1M Performance:

+1.53%

6M Performance:

-21.22%

1Y Performance:

-31.62%

1D Range:

$18.39

$18.91

52W Range:

$17.54

$30.15

Privia Health Group Inc Stock (PRVA) Company Profile

Name

Privia Health Group Inc

Sector

Healthcare (1223)

Industry

Health Information Services (61)

Phone

571 366 8850

Address

950 North Glebe Road, Suite 700, Arlington

Employee

559

Twitter

Next Earnings Date

2024-05-09

Latest SEC Filings

PRVA's Discussions on Twitter

Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-06-23	Initiated	JMP Securities	Mkt Outperform
Jun-13-23	Initiated	Evercore ISI	Outperform
Apr-12-23	Initiated	Stephens	Overweight
Mar-10-23	Initiated	RBC Capital Mkts	Outperform
Feb-03-23	Initiated	Goldman	Buy
Dec-09-22	Initiated	Stifel	Buy
Dec-08-22	Initiated	UBS	Buy
Sep-07-22	Resumed	Truist	Buy
May-03-22	Initiated	BofA Securities	Buy
Apr-28-22	Initiated	BTIG Research	Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Mar-30-22	Initiated	Guggenheim	Buy
Feb-22-22	Upgrade	Cowen	Market Perform → Outperform
Jan-03-22	Initiated	Jefferies	Buy
Sep-27-21	Initiated	SVB Leerink	Outperform
Sep-10-21	Initiated	Cowen	Market Perform
May-24-21	Initiated	Canaccord Genuity	Buy
May-24-21	Initiated	Credit Suisse	Outperform
May-24-21	Initiated	JP Morgan	Overweight
May-24-21	Initiated	Piper Sandler	Overweight
May-24-21	Initiated	Truist	Buy
May-24-21	Initiated	William Blair	Outperform

View All

Privia Health Group Inc Stock (PRVA) Latest News

Where Privia Health Gr Stands With Analysts

Benzinga

Analyst Scoreboard: 8 Ratings For Privia Health Gr

Benzinga

JP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To Know

Benzinga

Privia Health Group Inc Stock (PRVA) Financials Data

Privia Health Group Inc (PRVA) Revenue 2024

PRVA reported a revenue (TTM) of $1.66 billion for the quarter ending December 31, 2023, a +22.19% rise year-over-year.

Privia Health Group Inc (PRVA) Net Income 2024

PRVA net income (TTM) was $23.08 million for the quarter ending December 31, 2023, a +368.83% increase year-over-year.

Privia Health Group Inc (PRVA) Cash Flow 2024

PRVA recorded a free cash flow (TTM) of $80.67 million for the quarter ending December 31, 2023, a +71.31% increase year-over-year.

Privia Health Group Inc (PRVA) Earnings per Share 2024

PRVA earnings per share (TTM) was $0.19 for the quarter ending December 31, 2023, a +272.73% growth year-over-year.

Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.